LabCompass

Katelyn E. Swindle‐Reilly

Medicine · The Ohio State University

Mid career · publishing since 2006

Publications

53

Citations

1,178

Est. group size

~3

Recurring co-author estimate

Active years

20

Publishing since 2006

Research summary
AI-generated

Katelyn E. Swindle-Reilly works on biomaterials and drug-delivery systems for treating eye diseases, including hydrogel substitutes for the vitreous (the gel inside the eye), controlled-release particles for delivering drugs to the back of the eye, and injectable materials for treating optic nerve injury. Her work combines materials science with ophthalmology to address conditions like age-related macular degeneration, cataracts, and traumatic optic neuropathy.

Ocular drug delivery systemsHydrogel and polymer biomaterials for the eyeVitreous substitutesRetinal and optic nerve disease treatmentAntioxidant and controlled-release therapeutics

Publication output has grown from a low base around 2017-2019 to a steadier pace of roughly 5 papers per year since 2022, following a peak in 2020.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 4.2/year recently
2017: 2 publications172018: 2 publications182019: 3 publications192020: 7 publications7202021: 3 publications212022: 6 publications222023: 5 publications232024: 5 publications242025: 5 publications2526
Recent publications
Publishes in
  • Investigative Ophthalmology & Visual Science×7
  • Current Eye Research×4
  • Nanoscale×2
  • Journal of Biomedical Materials Research Part A×2
  • Journal of Controlled Release×2
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile